EUVIMED · CrossrefJournal
Bioanalysis
ISSN 1757-6180 · Informa UK Limited
Latest articles
Reframing immunosuppressant therapeutic drug monitoring: an integrated analytical framework based on microvolume whole blood
Anti-drug antibody titer may guide neutralizing antibody testing
Bioanalysis of antibody–drug conjugates: current practices and future directions—a workshop report
Quantification of D55, an apomorphine derivative, in mouse plasma by LC–MS/MS: method development, validation, and improved pharmacokinetics compared with apomorphine
Beyond measurement: a strategic perspective on antibody–drug conjugates bioanalysis from the European Bioanalysis Forum
Simultaneous LC–MS/MS quantification of four KRAS inhibitors (RMC-6236, RMC-9805, RMC-7977, and MRTX1133) in human plasma: toward therapeutic drug monitoring in pancreatic ductal adenocarcinoma
From detection to decisions: refocusing immunogenicity assessment on clinical relevance
The simultaneous detection of multidomain ADAs using a multiplex assay: a multiplexed approach to multidomain ADA detection
Human seminal fluid as a novel Forensic matrix for flualprazolam and α-hydroxy flualprazolam: development and validation of a sensitive SPE–UHPLC–MS/MS method and application to real samples
Anti-drug antibody assay validation and cut-point analysis: a practical guide for the non-statistician
Switchable hydrophilicity solvents and biosolvents for green microextraction in bioanalysis
Determination of subasumstat in human urine using LC-MS/MS
Optimization of hemolysis index thresholds for biochemical and immunoassays
Development and pre-qualification of a facile and ultra-sensitive LRRK2 LC/MS assay using high-affinity unmodified immobilization for immunocapture: meet bioanalytical challenges and search practical solutions
Bedside analysis of volatile organic compounds in exhaled human breath as non-invasive diagnostic tool for colon diseases
Applications of enzyme activity assays in clinical development for rare disease therapeutics
Application of sample stabilization and mass cytometry in global oncology trials: lessons from regulatory T cell monitoring
Bioanalytical assays for clinical similarity assessment of biotherapeutics: evolving platforms and regulatory considerations
A sensitive assay for estimation of DM1 fortified with trastuzumab in human serum utilizing positive LC-MS/MS electrospray ionization and its application to clinical study
European Bioanalysis Forum cross-industry perspective on emerging small-molecule modalities: bioanalytical challenges and potential mitigation strategies
Integrated microfluidic platform for the capture and identification of circulating tumor cells using dielectrophoresis and image recognition
Automated deep learning tool for robust colony counting in vaccine immunogenicity bioassays
Detection method for carrying Hepatitis B surface antigen exosomes by a chemiluminescence immunoassay (CLIA)
Opioid detection and quantification in alternative biological matrices: recent analytical advances
From analytical similarity to clinical confidence: how regulatory evolution ensures comparable immunogenicity in streamlined biosimilar development
From anti-drug antibody incidence to clinical relevance: interpreting highly sensitive immunogenicity assays in biosimilars
Advanced assay design for characterizing anti-drug antibody responses in clinical serum samples
Advancing beyond stand-alone NAb assays: perspectives and regulatory impact of applying integrated immunogenicity assessment in drug development
The Gyrolab platform for immunogenicity assessment and biotherapeutic and biomarker analysis: technical advances and bioanalytical applications
Consideration for immunogenicity assay development for oligonucleotide therapeutics
EUVIMED